L-Lysine: The Definitive Guide

What is L-Lysine?

L-lysine is an indispensable amino acid used in body proteins. The WHO adult requirement concerns total dietary lysine, while a capsule may declare free lysine, lysine hydrochloride or the lysine portion of a blend. The dietary requirement describes total intake from foods and supplements combined; it does not prescribe a powder. [1]

Typical L-Lysine Research Protocols

These rows reproduce studies. Do not average their populations, forms, frequencies or durations into one regimen.

Should L-Lysine be cycled?

No verified trial establishes a cycle. A review point can limit indefinite use, but it does not prove a physiological reset.

What happens when it is stopped?

No withdrawal syndrome is established. An acute or short study cannot predict persistence after stopping.

Which foods provide it?

Meat, fish, eggs, dairy, soy and other legumes provide indispensable amino acids within complete protein matrices. Portions and digestibility vary; a value in mg/kg/day concerns total dietary intake. [1]

Which forms and label details matter?

The Ghana paper reported that two tablets provided 1,200 mg/day lysine hydrochloride, described as approximately 1,000 mg/day lysine. Treat that as the paper’s rounded product declaration, not a universal salt-to-lysine conversion. A label that lists only a salt mass does not establish the free-lysine mass.

How should it be stored?

Follow the finished-product label, close the container and protect it from moisture and heat. Keep the lot number and discard a product with a broken seal or unexplained change.

What is L-Lysine commonly used for?

Lysine is marketed for protein support and recurrent cold sores. Nutrition evidence in people at risk of inadequate intake and herpes trials answer different questions. The herpes studies are old, small and conflicting; they do not support substituting lysine for antiviral diagnosis, prevention or treatment.

What does human research show?

The randomized 16-week Ghana study found less diarrheal morbidity in children and respiratory morbidity in men, but not a universal effect across subgroups; its nutritional setting does not establish a general immune dose. [2] A 2017 review judged the herpes literature too limited and inconsistent for a firm prophylaxis regimen. [3] In one older multicenter trial, 27 lysine and 25 placebo completers received 1,000 mg L-lysine three times daily for six months; recurrences, symptom severity and healing time favored lysine. [4] A separate 21-person trial using 400 mg lysine hydrochloride three times daily found no substantial treatment or prevention benefit. [5] Dose, salt declaration, sample size and era differ, so these trials do not establish a modern standard of care.

How might it act?

As an indispensable amino acid, L-Lysine contributes to protein synthesis and specific metabolic pathways. A normal biochemical role does not establish that a concentrated dose improves symptoms in someone whose intake is adequate.

What are the risks and interactions?

Gastrointestinal symptoms are possible with concentrated amino-acid products. Kidney or liver disease, pregnancy, breastfeeding, childhood use and inherited amino-acid disorders warrant clinician review. A 16-week trial in one nutritional setting does not define chronic safety or a supplement UL.

Which medicines can interact?

Product-specific interaction data are limited. Have the complete formula reviewed by a pharmacist when taking medicines, especially for neurologic, psychiatric, metabolic, kidney or liver conditions. Do not invent a universal separation interval.

Regulatory status: In the United States, supplements are not routinely approved for efficacy before sale. In Canada, check the NPN or DIN-HM and licensed label conditions. [6], [7]

What should be monitored?

Record product, lot, form, amount per administration, frequency, daily total, co-ingredients, dietary context, symptoms and intended outcome. Set a review date before starting.

Stop and seek advice for an allergic reaction, persistent vomiting, unusual weakness, confusion or another severe symptom.

What do public communities report?

Public discussions often emphasize taste, timing and felt effects while omitting lot, total diet and validated outcomes. This update did not independently recrawl or quantify those posts.

How does L-Lysine compare?

Common questions about L-Lysine

Does lysine prevent cold sores?

The small older trials conflict, and the 2017 review did not establish a firm prevention regimen. Do not replace antiviral care with lysine.

Did lower and higher herpes doses perform the same way?

No. A 1,200 mg/day lysine-HCl trial was null, while a six-month trial at 1,000 mg L-lysine three times daily favored lysine. Differences in product declarations and studies prevent a simple threshold claim.

Is 1,200 mg lysine HCl exactly 1,000 mg lysine?

That is the rounded relationship reported for the Ghana trial product. Do not apply it as a universal chemical conversion.

Does the Ghana trial apply to well-nourished adults?

Not directly. It enrolled households at risk of lysine inadequacy and found subgroup-specific morbidity results.

Can lysine treat an active herpes lesion?

The evidence is inconsistent and old. Seek diagnosis and evidence-based antiviral advice for recurrent or severe lesions.

What should I track?

Record free lysine versus hydrochloride, the declared lysine amount, each administration, recurrence timing, lesion duration, other treatments and the review date.

Glossary

Plain terms for interpreting the evidence.

Indispensable amino acid

An amino acid the diet must provide.

Dietary requirement

Total required intake; not a supplement dose.

Amount per administration

Amount consumed at one time, distinct from daily total.

NOAEL

Highest tested level without an observed adverse effect in one study; not automatically a UL.

UL

Tolerable Upper Intake Level established by an authority.

Biomarker

Biological measure that is not necessarily a felt or clinical benefit.

How this guide was researched

The complete WHO report, accessible primary human studies and live NCBI metadata were read on October 9, 2026. Titles, authors, journals, DOI, PMID, available PMCID and CommentsCorrections were checked. Open full text supplied methods details; an unreported frequency was not guessed. [1], [2], [3], [4], [5], [6], [7]

How this guide was made

Research and drafting were AI-assisted. This draft awaits Doserly editorial review and independent clinical review. See the editorial policy.

Explore the sources